Skip to main content
Top
Published in: Virchows Archiv 4/2007

01-04-2007 | Original Article

Cytological diagnosis of malignant mesothelioma—improvement by additional analysis of hyaluronic acid in pleural effusions

Authors: L. Welker, M. Müller, O. Holz, E. Vollmer, H. Magnussen, R. A. Jörres

Published in: Virchows Archiv | Issue 4/2007

Login to get access

Abstract

Cytology allows the diagnosis of malignant mesothelioma (MM) from effusions with high specificity but low sensitivity. Conversely, elevated levels of hyaluronic acid (HA) in effusions are sensitive indicators of MM, although specificity is insufficient. We studied whether the cytological diagnosis of MM could be improved by HA analysis. HA was analysed in patients with histologically confirmed MM (n = 162), adenocarcinoma or other malignant tumours (n = 100) and in 90 patients with benign pleural diseases. In 77 out of 162 effusions, all, and in 33 some, cytological criteria of MM were satisfied. The cut-off value of HA showing maximum diagnostic reliability (86%) regarding MM was 30 mg/l (sensitivity 87%, specificity 86%). A HA value of 100 mg/l yielded 39 and 98%, respectively. Seventy three out of 77 patients with cytological findings indicative of MM showed HA levels greater than 30 mg/l as well as 27 of 33 patients with suspicious lesions. These 100 patients were correctly recognised as having MM. The addition of HA analysis to cytology, requiring all or some criteria of MM as positive, increased sensitivity for MM from 48 to 71–91%, whereas specificity only slightly decreased to 94–96%. We conclude that the combined cytological and HA analysis of pleural effusions had the potential to improve the diagnosis of MM.
Literature
1.
go back to reference Achatzy R, Beba W, Ritschler R, Worn H, Wahlers B, Macha HN, Morgan JA (1989) The diagnosis, therapy and prognosis of diffuse malignant mesothelioma. Eur J Cardiothorac Surg 3:445–447PubMedCrossRef Achatzy R, Beba W, Ritschler R, Worn H, Wahlers B, Macha HN, Morgan JA (1989) The diagnosis, therapy and prognosis of diffuse malignant mesothelioma. Eur J Cardiothorac Surg 3:445–447PubMedCrossRef
2.
go back to reference Antman K, Shemin R, Ryan L, Klegar K, Osteen R, Herman T, Lederman G, Corson J (1988) Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana–Farber Cancer Institute and Brigham and Women’s Hospital experience over two decades, 1965–1985. J Clin Oncol 6:147–153PubMed Antman K, Shemin R, Ryan L, Klegar K, Osteen R, Herman T, Lederman G, Corson J (1988) Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana–Farber Cancer Institute and Brigham and Women’s Hospital experience over two decades, 1965–1985. J Clin Oncol 6:147–153PubMed
4.
go back to reference Atagi S, Ogawara M, Kawahara M, Sakatani M, Furuse K, Ueda E, Yamamoto S (1997) Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma. Jpn J Clin Oncol 27:293–297PubMedCrossRef Atagi S, Ogawara M, Kawahara M, Sakatani M, Furuse K, Ueda E, Yamamoto S (1997) Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma. Jpn J Clin Oncol 27:293–297PubMedCrossRef
5.
go back to reference Dahl IM, Solheim OP, Erikstein B, Müller E (1989) A longitudinal study of the hyaluronan level in the serum of patients with malignant mesothelioma under treatment. Hyaluronan as an indicator of progressive disease. Cancer 64:68–73PubMedCrossRef Dahl IM, Solheim OP, Erikstein B, Müller E (1989) A longitudinal study of the hyaluronan level in the serum of patients with malignant mesothelioma under treatment. Hyaluronan as an indicator of progressive disease. Cancer 64:68–73PubMedCrossRef
6.
go back to reference Friman C, Hellström PE, Juvani M, Riska H (1977) Acid glycosaminoglycans (mucopolysaccharides) in the differential diagnosis of pleural effusion. Clin Chim Acta 76:357–361PubMedCrossRef Friman C, Hellström PE, Juvani M, Riska H (1977) Acid glycosaminoglycans (mucopolysaccharides) in the differential diagnosis of pleural effusion. Clin Chim Acta 76:357–361PubMedCrossRef
7.
go back to reference Fuhrman C, Duche JC, Chouaid C, Abd Alsamad I, Atassi K, Monnet I, Tillement JP, Housset B (2000) Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies. Clin Biochem 33:405–410PubMedCrossRef Fuhrman C, Duche JC, Chouaid C, Abd Alsamad I, Atassi K, Monnet I, Tillement JP, Housset B (2000) Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies. Clin Biochem 33:405–410PubMedCrossRef
8.
go back to reference Hillerdal G, Lindqvist U, Engström-Laurent A (1991) Hyaluronan in pleural effusions and in serum. Cancer 67:2410–2414PubMedCrossRef Hillerdal G, Lindqvist U, Engström-Laurent A (1991) Hyaluronan in pleural effusions and in serum. Cancer 67:2410–2414PubMedCrossRef
9.
go back to reference Martensson G (1990) Diagnosing malignant pleural mesothelioma. Eur Respir J 3:985–986PubMed Martensson G (1990) Diagnosing malignant pleural mesothelioma. Eur Respir J 3:985–986PubMed
10.
go back to reference Martensson G, Thylen A, Lindquist U, Hjerpe A (1994) The sensitivity of hyaluronan analysis of pleural fluid from patients with malignant mesothelioma and a comparison of different methods. Cancer 73:1406–1410PubMedCrossRef Martensson G, Thylen A, Lindquist U, Hjerpe A (1994) The sensitivity of hyaluronan analysis of pleural fluid from patients with malignant mesothelioma and a comparison of different methods. Cancer 73:1406–1410PubMedCrossRef
11.
go back to reference Matzel W (1985) Biochemical and cytological features of diffuse mesotheliomas of the pleura. Arch Geschwulstforsch 55:259–64PubMed Matzel W (1985) Biochemical and cytological features of diffuse mesotheliomas of the pleura. Arch Geschwulstforsch 55:259–64PubMed
12.
go back to reference Meyer K, Chaffee E (1939) Hyaluronic acid in pleural fluid associated with malignant tumour involving pleura and peritoneum. Pro Soc Exp Biol Med 42:797–800 Meyer K, Chaffee E (1939) Hyaluronic acid in pleural fluid associated with malignant tumour involving pleura and peritoneum. Pro Soc Exp Biol Med 42:797–800
13.
go back to reference Parker C, Neville E (2003) Lung cancer * 8: management of malignant mesothelioma 1. Thorax 58:809–813PubMedCrossRef Parker C, Neville E (2003) Lung cancer * 8: management of malignant mesothelioma 1. Thorax 58:809–813PubMedCrossRef
14.
go back to reference Peto J, Decarli A, La Vecchia C, Levi F, Negri E (1999) The European mesothelioma epidemic. Br J Cancer 79:666–672PubMedCrossRef Peto J, Decarli A, La Vecchia C, Levi F, Negri E (1999) The European mesothelioma epidemic. Br J Cancer 79:666–672PubMedCrossRef
15.
go back to reference Pettersson T, Froseth B, Riska H, Klockars M (1988) Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma. Chest 94:1037–1039PubMed Pettersson T, Froseth B, Riska H, Klockars M (1988) Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma. Chest 94:1037–1039PubMed
16.
go back to reference Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES (1997) The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 111:106–109PubMed Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES (1997) The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 111:106–109PubMed
17.
go back to reference Spriggs AI, Boddington MM (1994) Atlas of serous fluid cytopathology. A guide to the cells of pleural, pericardial, peritoneal and hydrocele fluid. In: Gresham GA (ed) Current histopathology series, vol 14. Kluwer, Dordrecht (1989) Spriggs AI, Boddington MM (1994) Atlas of serous fluid cytopathology. A guide to the cells of pleural, pericardial, peritoneal and hydrocele fluid. In: Gresham GA (ed) Current histopathology series, vol 14. Kluwer, Dordrecht (1989)
18.
go back to reference Stevens MW, Leong AS, Fazzalari NL, Dowling KD, Henderson DW (1992) Cytopathology of malignant mesothelioma: a stepwise logistic regression analysis. Diagn Cytopathol 8:333–341PubMedCrossRef Stevens MW, Leong AS, Fazzalari NL, Dowling KD, Henderson DW (1992) Cytopathology of malignant mesothelioma: a stepwise logistic regression analysis. Diagn Cytopathol 8:333–341PubMedCrossRef
19.
go back to reference Thylen A, Hjerpe A, Martensson G (2001) Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma. Cancer 92:1224–1230PubMedCrossRef Thylen A, Hjerpe A, Martensson G (2001) Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma. Cancer 92:1224–1230PubMedCrossRef
20.
go back to reference Welker L, Jörres RA, Costabel U, Magnussen H (2004) Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 24:1000–1006PubMedCrossRef Welker L, Jörres RA, Costabel U, Magnussen H (2004) Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 24:1000–1006PubMedCrossRef
Metadata
Title
Cytological diagnosis of malignant mesothelioma—improvement by additional analysis of hyaluronic acid in pleural effusions
Authors
L. Welker
M. Müller
O. Holz
E. Vollmer
H. Magnussen
R. A. Jörres
Publication date
01-04-2007
Publisher
Springer-Verlag
Published in
Virchows Archiv / Issue 4/2007
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-007-0375-x

Other articles of this Issue 4/2007

Virchows Archiv 4/2007 Go to the issue